latest news releases from the newsroom
Pergo and Unilin Reach Settlement
STOCKHOLM, Sweden, Nov. 9, 2004 (PRIMEZONE) -- Pergo and Unilin have reached an agreement to settle all outstanding issues relating to glue free laminate flooring joint systems.
TeliaSonera Launches a Pan-Nordic Phone Conference Service
STOCKHOLM, Sweden, Nov. 09, 2004 (PRIMEZONE) -- TeliaSonera provides a new phone conference service for companies operating in the Nordic countries. The service makes it increasingly easier for participants in different countries to organize a meeting, and at a lower cost. The demand for conferencing services is increasing, as more and more companies operating on the international market want to save travel costs and time.
AB Volvo Announces Share Repurchase
GOTEBORG, Sweden, Nov. 9, 2004 (PRIMEZONE) -- Further to the decision taken by AB Volvo's Board of Directors on June 17, 2004, regarding repurchase of own shares, AB Volvo has, on Monday, November 8, acquired 225,000 series B shares. The shares were traded between SEK 275.50 and 278.50 with an average price of SEK 277.46.
Crucell N.V.: Wyeth Selects Novel Drug Targets in Osteoporosis Collaboration With Galapagos
LEIDEN, The Netherlands and MECHELEN, Belgium, Nov. 9, 2004 (PRIMEZONE) -- Galapagos Genomics announced today that it has reached a research milestone in its osteoporosis discovery program with Wyeth Pharmaceuticals, the pharmaceutical division of Wyeth (NYSE:WYE). Within the program, which was initiated November 2003, Galapagos has used its osteoporosis disease expertise in combination with its SilenceSelect(tm) adenoviral siRNA platform to discover and validate novel drug targets that may affect bone remodeling. Wyeth has now selected a set of these targets for internal development, triggering a financial milestone for Galapagos. As these targets are progressed by Wyeth, Galapagos has rights to additional milestone payments that could amount up to $40 million.